Investigation of selective glucocorticoid receptor modulation in high-grade serous ovarian cancer PDX models is a research paper published in Journal of Gynecologic Oncology (2024). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Mayo Clinic SPORE in Ovarian Cancer Developmental Research Program, Pilot Study Award
Grant: 5P50CA136393-09
Mayo Clinic Ovarian Cancer SPORE
2017 Conquer Cancer Foundation/ASCO Young Investigator Award
Grant: NIH1R21CA223426
Cancer Prevention Research Institute of Texas Recruitment of Established Investigators Award
Grant: RR1900371
National Cancer Institute
Grant: P30 CA142543
The University of Chicago Comprehensive Cancer Center
Grant: P30 CA 14599
NCI NIH HHS
Grant: P30 CA014599
NCI NIH HHS
Grant: R21 CA223426
NCI NIH HHS
Grant: P50 CA136393
National Institutes of Health
Grant: 7R21CA223426-02
Identification of a prognostic and predictive glucocorticoid receptor signature for ovarian cancer
National Institutes of Health
Grant: 3P30CA142543-12S1
Multidimensional single-cell approach probing HIV-1 integration association with non-AIDS defining cancers (Biospecimens/Biocohort)
National Institutes of Health
Grant: 3P30CA014599-36S1
Cancer Center Support Grant
The University of Chicago Women's Board
The University of Chicago Women’s Board
FWCI
0.77
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals